Trial Profile
An extended, observational study in paediatric patients with chronic hepatitis B who have previously received long-term Lamivudine treatment
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 13 Jul 2005
Price :
$35
*
At a glance
- Drugs Lamivudine (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 13 Jul 2005 New trial record.